ArticleCancer discovery2022
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma.
Adam D Durbin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
101 papers cite itlatest 60 shown
this paperpooled itcites it